1. Differential Utility Losses in Herpes Zoster Cases Between Vaccinated and Unvaccinated Subjects: A Meta-analysis of Three Clinical Trials

   • Nikolaos Giannelos
   • Bernard Francq
   • Desmond Curran

   Original Research Article Open access 25 April 2024 Pages: 293 - 301

   

2. Impact of Viloxazine Extended-Release Capsules (Qelbree^®) on Select Cytochrome P450 Enzyme Activity and Evaluation of CYP2D6 Genetic Polymorphisms on Viloxazine Pharmacokinetics

   • Zhao Wang
   • Tesfaye Liranso
   • Azmi Nasser

   Original Research Article Open access 10 April 2024 Pages: 303 - 317

   

3. Safety, Tolerability, and Pharmacokinetics of Oral BI 1358894 in Healthy Japanese Male Volunteers

   • Jangsoo Yoon
   • Vikas Sharma
   • Akiko Harada

   Original Research Article Open access 24 April 2024 Pages: 319 - 328

   

4. Risk of Cardiovascular Events in Schizophrenic Patients Treated with Paliperidone Palmitate Once-Monthly Injection (PP1M): A Population-Based Retrospective Cohort Study in Taiwan

   • Shih-Pei Shen
   • Li Yan
   • Chao-Hsiun Tang

   Original Research Article Open access 15 April 2024 Pages: 329 - 341

   

5. Pharmacokinetic Interactions Between Tegoprazan and the Combination of Clarithromycin, Amoxicillin and Bismuth in Healthy Chinese Subjects: An Open-Label, Single-Center, Multiple-Dosage, Self-Controlled, Phase I Trial

   • Yujing Du
   • Lixiu Yu
   • Yongning Lu

   Original Research Article 13 April 2024 Pages: 343 - 355

   

6. Prediction Model for Severe Thrombocytopenia Induced by Gemcitabine Plus Cisplatin Combination Therapy in Patients with Urothelial Cancer

   • Noriaki Matsumoto
   • Tomohiro Mizuno
   • Shigeki Yamada

   Original Research Article 29 April 2024 Pages: 357 - 366

   

7. PB006: A Natalizumab Biosimilar

   • Matt Shirley

   Adis Biosimilar Brief 29 April 2024 Pages: 367 - 370